logo
Country legend's granddaughter asks for prayers after daughter rushed to hospital

Country legend's granddaughter asks for prayers after daughter rushed to hospital

Yahoo25-07-2025
Emmy Russell, the granddaughter of Loretta Lynn, is dealing with a scary situation involving her daughter.
Russell, who rose to fame last year on 'American Idol,' and her husband, singer-songwriter Tyler Ward, shared an Instagram video on Sunday asking for prayers for their daughter, Taylor Raydiant, who was born earlier this year.
'Taylor has been fussy & crying for the last few days and we assumed it was teething... but this morning Tyler noticed small spasms,' the couple wrote in the video's caption.
'We filmed it and rushed to the doctor. They confirmed it could be small seizures and asked us to stay overnight for testing,' they wrote. 'It's a different kind of hard right now. We're asking for your prayers, we truly believe they could make all the difference tonight.'
Read More: Country legend's granddaughter shares how 'American Idol' made her 'so mad'
Russell added that Taylor was getting an EEG to record her brain wave activity.
'She's been having these spasms, kind of just like she's falling almost,' she explained in the video. 'They were just really concerned about it and wanted to do some checking how our brain is and everything.'
With that, the couple asked for answers and prayers from fans on social media.
'My daughter was diagnosed with focal seizures at 4ish months old. I'm happy to say she's been 4 months seizure free,' an Instagram user commented. 'Always trust your gut. Always advocate for your child. Praying for you guys and for answers!'
Read More: Here's why a country music legend's granddaughter cried on 'American Idol'
'My youngest started having seizures the week before he turned one. We did all the testing, all the hospital visits, all the meds for a year and nothing improved,' another user commented. 'We finally went to a chiropractor as a last resort option and after weekly treatments he finally grew out of it. Hugs momma! It will be okay. I know it's so hard and so scary.'
The couple shared an update on Monday, writing, 'Alright y'all – thank you for your prayers for Taylor. She did the spasm thing this morning. She has the EEG, so we will see what her results are and next steps. The neurologist should be coming in very soon. Please continue to pray.'
Russell gave birth to Taylor in February, but immediately experienced some complications that left Russell in the hospital.
Read More: Country music legend's granddaughter to audition on 'American Idol'
'Gave birth Friday morning at 2:30 am and it was a really really tough situation. And she's still here in the hospital. We almost got discharged. And then this,' Ward said in an Instagram video posted Feb. 3.
Russell then explained that she needed a blood transfusion after losing 1.6 liters of blood after giving birth to their baby.
She updated fans in a Feb. 5 Instagram video after being discharged from the hospital.
More Country Music News
Surgery scheduled for country music icon recovering from onstage stroke
'I can't sing anymore': Country star offers refunds after losing voice on stage
Country music legend plays for fans while awaiting surgery after stroke
Country music star charged with misdemeanor in fatal crash
Popular 2000s country artist loses younger brother in Texas floods
Read the original article on MassLive.
Solve the daily Crossword
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Exhale Wellness Recognized as the #1 Delta 9 THC Gummies by Onpattison
Exhale Wellness Recognized as the #1 Delta 9 THC Gummies by Onpattison

Yahoo

time5 minutes ago

  • Yahoo

Exhale Wellness Recognized as the #1 Delta 9 THC Gummies by Onpattison

Exhale Wellness earns top spot for best Delta 9 gummies in 2025, recognized for quality, transparency, and customer satisfaction by Onpattison. Charlotte, NC, Aug. 04, 2025 (GLOBE NEWSWIRE) -- Onpattison has named Exhale Wellness the #1 Delta 9 gummy brand in its 2025 rankings, citing the company's emphasis on clean formulations, product transparency, and third-party testing. The annual list, compiled by the publication's wellness editorial team, highlighted 5 standout hemp-derived THC products that met high standards for safety, effectiveness, and consumer trust. Exhale Wellness's plant-based approach and commitment to rigorous quality control played a key role in securing the top spot for the brand. What Are Delta 9 Gummies? Delta 9 gummies are edible products containing Delta 9 tetrahydrocannabinol (THC), the primary psychoactive compound in cannabis. When sourced from federally legal hemp and formulated within compliant THC limits (less than 0.3% Delta 9 THC), these gummies offer a controlled, predictable way to consume THC. In its 2025 ranking, Onpattison recognized brands that deliver not only efficacy but also transparency and consumer safety in their Delta 9 offerings, criteria that Exhale Wellness met with distinction. Delta 9 THC Gummies: The Flagship Behind the #1 RankingAt the center of Onpattison's ranking is Exhale Wellness's Delta-9 Bottle Caps, the company's flagship gummy product. Editors cited the product's balanced potency, full-spectrum formulation, and transparency in testing as key reasons for awarding Exhale the top spot. Each bottle contains 450 mg of hemp-derived Delta 9 THC, formulated from full-spectrum hemp extract to preserve the natural cannabinoid and terpene profile. This approach contributes to what users often describe as a more rounded, longer-lasting experience compared to isolates. Bottle Caps were also recognized for their clean formulation, including vegan ingredients and naturally flavored profiles such as Cherry Cola, Lemon-Lime, and Orange. Exhale's use of U.S.-grown hemp and third-party lab testing ensures that each batch meets federal compliance standards outlined in the 2018 Farm Bill. In this context, Exhale's published Certificates of Analysis (COAs), available to consumers, were noted as a strong indicator of transparency and consumer trust. Additional Features That Contributed to the Best Ranking In naming Exhale Wellness the #1 Delta 9 thc gummy brand of 2025, Onpattison highlighted several distinguishing factors beyond formulation alone. One was consistency in potency, with each gummy delivering a reliable 15 mg of hemp-derived Delta 9 THC, an important element for responsible dosing and user experience. The product's clean, vegan formulation was also a factor in the ranking. Made with plant-based pectin, natural flavors, and free from artificial additives, Bottle Caps reflects growing consumer demand for health-conscious, non-GMO edibles. While the Bottle Caps line is relatively new, Onpattison noted Exhale's overall brand reputation for quality and transparency. Across its product offerings, Exhale has earned strong consumer reviews for consistency, ease of use, and customer service, qualities that helped set the brand apart in a competitive evaluation process. Why Exhale Wellness Was Chosen as Delta 9 Gummies? Exhale Wellness earned the top spot in Onpattison's 2025 Delta 9 thc gummy rankings due to its commitment to product integrity, transparency, and user trust. The evaluation highlighted several standout factors that contributed to the brand's placement: Transparent Sourcing and Lab TestingEach batch of Exhale's Delta 9 gummies is verified through third-party lab testing, with publicly available Certificates of Analysis (COAs) confirming cannabinoid content, potency, and product safety. This level of transparency was a key differentiator in the ranking process. Clean, Plant-Based FormulationsThe editorial team emphasized Exhale's use of organic, non-GMO ingredients and vegan-friendly formulations made without artificial additives. The use of pectin over gelatin reflects a thoughtful approach to ingredient sourcing. Established Brand ReputationWhile Bottle Caps is one of the newer products in Exhale's portfolio, the brand's track record of quality and responsiveness was cited as a contributing factor. Consistent consumer satisfaction across Exhale's broader product line reinforced its credibility. Balanced Potency and Full-Spectrum EffectThe magazine also acknowledged the company's use of full-spectrum hemp extract, which preserves a range of cannabinoids and terpenes for a more comprehensive user experience. This format, paired with clearly labeled dosing, supports a wide range of consumer preferences. Editorial Criteria That Set Exhale Wellness Apart In evaluating the best Delta 9 THC gummies for its 2025 ranking, Onpattison applied a broad set of criteria reflecting the current standards for product quality and consumer trust. Exhale Wellness met or exceeded expectations across the following key areas: Sourcing and Agricultural Standards Exhale uses hemp grown in the United States under regulated agricultural practices, minimizing exposure to pesticides, heavy metals, or synthetic additives. Domestic sourcing was a baseline requirement in the magazine's review process. Potency and Dose TransparencyEach gummy contains a clearly labeled 15 mg of Delta 9 THC. The publication highlighted brands that offer reliable, consistent dosing, a crucial element for consumers managing intake responsibly. Clean Ingredient Profile Formulations were evaluated for ingredient transparency. Exhale's plant-based, vegan gummies, made without artificial colorants or high-fructose corn syrup, were noted for addressing evolving consumer preferences. Third-Party Lab Testing and COA Access Brands without published lab results were excluded from consideration. Exhale's publicly accessible Certificates of Analysis (COAs) confirmed potency, cannabinoid breakdown, and absence of contaminants. Flavor and Product Consistency Taste and texture factored into the overall experience. Exhale's use of natural flavoring and consistent formulation across batches contributed positively to its assessment. Responsiveness Exhale's reputation for customer support, shipping reliability, and product consistency helped distinguish it in a crowded market. Editorial staff considered both consumer sentiment and company transparency during the review. Legal Compliance All selected brands were required to meet the 2018 Farm Bill threshold of 0.3% Delta 9 THC by dry weight. Exhale's compliance was verified through both internal documentation and third-party reports. Exhale Wellness's Delta 9 Gummies Availability Exhale Wellness's Delta 9 gummies, including the award-winning Bottle Caps line, are available for purchase through the company's official website. Each product listing includes detailed lab reports (COAs), ingredient information, and dosage specifications to support consumer transparency. All Exhale Wellness Delta 9 THC products comply with the 2018 Farm Bill, containing no more than 0.3% THC by dry weight. Products are available for shipment to states where hemp-derived Delta 9 THC is permitted, and all customers must be 21 years or older to purchase. Shipping practices adhere to federal and state-level compliance requirements. FAQs about Delta THC Gummies What is Delta 9 THC? Delta 9 tetrahydrocannabinol (THC) is the primary psychoactive compound found in cannabis. It interacts with the body's endocannabinoid system and is known for producing effects such as euphoria and relaxation. When derived from hemp and used within legal limits, it can be formulated into federally compliant wellness products. Are Exhale Wellness's Delta 9 Gummies Legal? Yes. Exhale Wellness's Delta 9 gummies are made from hemp-derived THC and contain no more than 0.3% Delta 9 THC by dry weight, in accordance with the 2018 Farm Bill. Federal legality does not guarantee state-level approval, so consumers are advised to check local laws before purchasing. What makes Exhale Wellness different from other Delta 9 gummy brands? Exhale Wellness was recognized by Onpattison for its product consistency, lab-tested transparency, and clean ingredient profile. The brand uses non-GMO, vegan-friendly formulations and publishes third-party Certificates of Analysis for every batch. How strong are the best Delta 9 Gummies from Exhale Wellness? Each gummy contains 15 mg of hemp-derived Delta 9 THC. This dosage format offers a balanced and consistent experience and is intended to support responsible use among both new and experienced consumers. Do Exhale Wellness's gummies ship nationwide? Exhale Wellness ships to U.S. states where hemp-derived Delta 9 THC products are legally permitted. While the products are federally legal, shipping availability is subject to state-specific regulations. How long do the effects last? The effects of hemp-derived Delta 9 gummies typically last between 6 and 9 hours, depending on individual factors such as body chemistry, metabolism, and tolerance. Onset time may be delayed due to digestion. How should Delta 9 THC be dosed? Dosing recommendations vary by user. For those new to Delta 9 THC, a lower dose (such as 2.5 to 5 mg) is generally suggested to gauge individual response. Gradual adjustment over time can help maintain a safe and comfortable experience. Conclusion Exhale Wellness's selection as the top Delta 9 gummy brand in Onpattison's 2025 rankings reflects the company's emphasis on ingredient transparency, consistent dosing, and third-party lab testing. The recognition highlights Exhale's approach to federally compliant hemp products at a time when consumer standards for quality and accountability in the wellness space are rising. For more information, visit CONTACT: Company Name: Exhale Wellness Phone Number: (323) 448-3810 Email: support@ Official Address: Charlotte, NC 28273, United StatesSign in to access your portfolio

Katy Perry brings pop spectacle to Detroit, prays aloud after fan medical incident onstage
Katy Perry brings pop spectacle to Detroit, prays aloud after fan medical incident onstage

Yahoo

time5 minutes ago

  • Yahoo

Katy Perry brings pop spectacle to Detroit, prays aloud after fan medical incident onstage

Katy Perry didn't wait long Sunday night to get the wacky performance high jinks going at Little Caesars Arena. Lifted high above her figure-eight stage, ensconced in a rig of illuminated hoops and wired up like an android, the pop star kicked off what promised to be a two-hour fun ride for an adoring Detroit audience. Still, there was one scary moment 80 minutes into the show, instantly bringing the arena to a hush: A young fan invited onstage for a sing-along segment abruptly collapsed as Perry prepared to launch into song. The girl, who looked to be in her early teens, appeared overwhelmed from the moment she walked to the stage, when she broke into tears and wrapped her arms around the star in a long embrace. As security and medical staffers rushed up after her collapse, Perry kicked into mom mode, crouching down and offering words of encouragement. The fan was ultimately joined by her mother and treated at the backstage first aid area, a show official told the Free Press, though no further updates were available late Sunday. Onstage, Perry rounded up three other young fans in a group hug and offered a prayer for the ailing girl. Perry, now 40 and mother of a 4-year-old daughter, was making her first Detroit visit in eight years as part of her global Lifetimes Tour. Which means — by a rough eyeball estimate — about 20% of Sunday's crowd wasn't yet born the last time she played LCA. It was clear the millennials who made up the pop star's early KatyCats fandom were now back with their own kids in tow, many of them attired in sparkly outfits and song-inspired costumes. Perry arrived at LCA at a seeming career crossroads, with a much-maligned new album and naysayers arguing she's in need a musical refresh. Early videos from the tour had zeroed in on her clunky moves and jumping-jack dances. Her stature at the forefront of the pop zeitgeist increasingly appeared locked in a 2015 time capsule. But Perry's performance Sunday was infectious, bold and unapologetic — by no means the cringeworthy disaster it was painted as when those viral clips made her an internet punching bag this spring. Silliness has long been part of the Katy Perry shtick, sharing equal billing with her soaring choruses and upbeat affirmations. And so taken on its own terms – a pop concert initiation for young fans – Sunday's show was a perfectly fine arena spectacle. 'They can say what they want to say,' Perry told the crowd during a late-show performance of 'Part of Me,' which included her go at twerking. 'But this is who I am.' It was a night of metal contraptions, high-flying adventures over the crowd, cartoonishly oversized props and cyberpunk imagery with a whimsical flavor. The concert unfolded with Perry as a character stepping up levels in a live-action video game. Sure, she's no virtuoso on the dance and choreography front, with moves that owe more to jazzercise than to Janet Jackson. But her 10-man backing troupe was there to pick up that slack, leaving room for Perry to do her main thing — like battling a masked ninja with a two-sided lightsaber, as she did on 'E.T.' She spent plenty of time up in the air: 'Roar' had her riding overhead on a giant butterfly, 'Nirvana' was a high-flying moment in a Pink-style harness, 'I Kissed a Girl' raised her up in a scaffolded globe. Songs from last year's '143' album were heavily sprinkled among the old hits most fans had flocked to LCA to hear. 'Dark Horse' was the night's first big crowd igniter, part of a litany of signature smashes that included 'California Gurls,' 'Teenage Dream,' 'Hot n Cold,' 'Last Friday Night (T.G.I.F.)' and a souped-up EDM rendition of 'Wide Awake.' The anthemic stuff came late in the set, as 'Part of Me,' 'Rise' and 'Roar' built to Perry's requisite climactic moment: a rousing closing performance of 'Firework.' Contact Detroit Free Press music writer Brian McCollum: 313-223-4450 or bmccollum@ This article originally appeared on Detroit Free Press: Katy Perry brings pop spectacle to Detroit, prays after fan medical event Solve the daily Crossword

Cannabis Use Disorder Tied to Benign Salivary Tumors
Cannabis Use Disorder Tied to Benign Salivary Tumors

Medscape

time6 minutes ago

  • Medscape

Cannabis Use Disorder Tied to Benign Salivary Tumors

TOPLINE: Cannabis use disorder (CUD) was associated with a greater than fivefold increased risk for benign tumors of major salivary glands compared to not having CUD, a new retrospective study showed. Additionally, the elevated risk persisted beyond 5 years of follow-up and particularly affected the parotid salivary gland. METHODOLOGY: As previous research showed a link between cigarette smoking and benign gland tumors, the current investigators wanted to assess whether CUD was also associated with these tumors. In this retrospective cohort study, they analyzed electronic medical records from 66 US-based healthcare organizations. Incidence of any benign major salivary gland tumor and parotid salivary gland tumor was compared between nearly 184,000 adults with a history of hospital outpatient visit and CUD and more than 6 million individuals without CUD between 2005 and 2025. Propensity score matching was applied to adjust for clinical characteristics, including age, race, ethnicity, tobacco use, nicotine use disorder, and a history of radiation. TAKEAWAY: The incidence of benign tumor of any major salivary gland and that of the parotid salivary gland was higher in the CUD group than in the non-CUD group (0.08 vs 0.02% and 0.05 vs 0.01%, respectively). Relative risk for any benign major salivary gland tumor was higher in the CUD vs non-CUD group at all timepoints between index event and outcome assessment (risk ratio [RR] for any time, 5.2; RR for 0-5 years, 4.3; RR for ≥ 5 years, 5.0). Relative risk for benign tumor of the parotid salivary gland was also increased after a diagnosis of CUD (RR for any time, 5.2; RR for 0-5 years, 4.9; RR for ≥ 5 years, 3.9). IN PRACTICE: 'The elevated relative risk of benign parotid tumors and the persistent association over time highlight potential site-specific outcomes of cannabis use,' the investigators wrote. 'Future prospective research with large samples and data on cannabis doing, method of use, and benign salivary gland neoplasm pathology is required to further assess and confirm this association,' they added. SOURCE: The study was led by Tyler J. Gallagher, MD, Keck School of Medicine, University of Southern California, Los Angeles. It was published online on July 17 in JAMA Otolaryngology-Head & Neck Surgery. LIMITATIONS: The study was constrained by the absence of cannabis dosage information and histologic data on benign salivary gland tumors and a limited long-term follow-up. DISCLOSURES: The investigators reported having no relevant conflicts of interest. This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store